Infliximab therapy in a child with Kawasaki disease 2 weeks after receiving rotavirus vaccination
Pediatrics International · 2026-01 · 68 (1)
DOI: 10.1111/ped.70359 ↗At a glance
Journal article in Pediatrics International, published online on 2026-03-16. Written by Daisuke Shimizu and 6 co-authors. Institution: Department of Pediatrics, Kyushu Hospital, Japan Community Healthcare Organization, Kitakyushu, Japan. 7 references.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
Author keywords
Authors and institutions
- Department of Pediatrics, Kyushu Hospital, Japan Community Healthcare Organization, Kitakyushu, Japan.
- Department of Pediatrics, University of Occupational and Environmental Health, Kitakyushu, Japan.
- Department of Pediatrics, Kokura Medical Center, National Hospital Organization, Kitakyushu, Japan.
ORCID profiles: Daisuke Shimizu, Jun Muneuchi
Cite
APA
Shimizu, D., Muneuchi, J., Toyomura, D., Nakashima, Y., Sugitani, Y., Watanabe, M., & Ohno, T. (2026). Infliximab therapy in a child with Kawasaki disease 2 weeks after receiving rotavirus vaccination. Pediatrics International, 68(1). https://doi.org/10.1111/ped.70359
Vancouver
Shimizu D, Muneuchi J, Toyomura D, Nakashima Y, Sugitani Y, Watanabe M, et al. Infliximab therapy in a child with Kawasaki disease 2 weeks after receiving rotavirus vaccination. Pediatrics International. 2026;68(1). doi:10.1111/ped.70359
BibTeX
@article{Shimizu2026,
author = {Shimizu, Daisuke and Muneuchi, Jun and Toyomura, Daisuke and Nakashima, Yasutaka and Sugitani, Yuichiro and Watanabe, Mamie and Ohno, Takuro},
title = {Infliximab therapy in a child with Kawasaki disease 2 weeks after receiving rotavirus vaccination},
journal = {Pediatrics International},
year = {2026},
volume = {68},
number = {1},
doi = {10.1111/ped.70359}
}
EUVIMED